CLB vs DEC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CLB exhibits a concerning divergence between its current market price ($17.45) and its deterministic value markers, with a Piotroski F-Score of 4/9 indicating only stable health. The stock is trading at a significant premium to both its Graham Number ($9.04) and Intrinsic Value ($4.41), while experiencing a sharp YoY earnings decline of 31.60%. Despite a strong 1-year price rally, the underlying fundamentals—specifically the negative earnings growth and bearish technical trend—suggest the current valuation is unsustainable.
DEC presents a classic deep-value opportunity, trading at a significant discount to its Graham Number ($36.29) and Intrinsic Value ($32.06). While the Piotroski F-Score of 5/9 indicates stable financial health, the company carries high leverage (Debt/Equity 3.04) and weak short-term liquidity (Current Ratio 0.60). However, these risks are offset by exceptional profitability metrics, including an ROE of 48.60% and explosive revenue growth of 95.70%. The combination of a very low P/E (3.38) and a sustainable high-yield dividend makes it an attractive risk-reward play despite bearish insider activity.
Compare Another Pair
Related Comparisons
CLB vs DEC: Head-to-Head Comparison
This page compares Core Laboratories Inc. (CLB) and Diversified Energy Company (DEC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.